We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


NIH Extends Agreement with Galapagos Until End 2012

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "NIH Extends Agreement with Galapagos Until End 2012"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:
Galapagos NV has announced that the U.S. National Institutes of Health (NIH) have extended their agreement with Galapagos' service division BioFocus for the operation of the Molecular Libraries Small Molecule Repository (MLSMR) through December 2012.

According to the terms of this agreement, Galapagos will be eligible to receive up to $8.6 million (€7.0 million) over the course of the two year extension.

BioFocus runs a compound management facility for a number of industrial and U.S. government customers out of its Compound Focus, Inc. subsidiary in South San Francisco. Home to the MLSMR since 2004, this facility acquires and stores compounds under the NIH contract and distributes these compounds for high-throughput biological screening throughout the NIH's academic network in the U.S.

"We are pleased that the NIH has exercised its option to extend its long-standing collaboration with BioFocus' compound management facility for another two years. BioFocus has proven that it consistently delivers a high-quality service across the vast NIH screening center network," said Onno van de Stolpe, CEO of Galapagos.